Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of July 2021, specifically dated July 29, 2021. The document reports on a corporate governance event rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to shareholder meeting logistics.
Material Changes
No material financial changes are reported. The primary event is the adjournment of a Special Meeting of Shareholders originally convened on July 29, 2021, due to a lack of quorum.
Outlook and Management Commentary
Management has scheduled a reconvened Special Meeting for Thursday, August 5, 2021, at 3:00 p.m. Israel time. The meeting will be held at the Company's offices at 10 Bareket Street, Petach Tikva, Israel. No specific risks, contingencies, or unusual items are detailed in this text.
Key Facts for Investors
- The Special Meeting of Shareholders on July 29, 2021, was adjourned due to insufficient quorum.
- The meeting is rescheduled for August 5, 2021, at the same time and location.
- This filing contains no financial data or operational updates.